What's Happening?
Liquid Death is among several companies, including David Protein, Liquid IV, WK Kellogg, and Kind, facing a wave of proposed class action lawsuits. These lawsuits allege false advertising and consumer protection violations regarding 'zero sugar' and 'sugar
free' claims on products that contain allulose. The core argument of the complaints is that allulose, a monosaccharide, falls under the FDA's regulatory definition of sugar. Therefore, plaintiffs contend that labeling products with allulose as 'zero sugar' or 'sugar free' is misleading to consumers, especially since a 2021 survey indicated that only 15% of respondents were aware that allulose is a form of sugar. The legal theory behind these cases closely tracks a recent Seventh Circuit Court of Appeals decision that allowed a similar lawsuit against Chobani to proceed, asserting that 'sugar free' claims require less than 0.5 grams of sugar per serving, and allulose must be counted as sugar for this threshold.
Why It's Important?
This wave of litigation is significant because it challenges the marketing practices of numerous food and beverage companies that use allulose as a low-calorie sweetener. If these lawsuits are successful, they could force a re-evaluation of 'zero sugar' and 'sugar free' labeling across the industry, potentially leading to widespread changes in product formulations and marketing strategies. The legal precedent set by the Seventh Circuit Court's decision against Chobani has created uncertainty for companies relying on the FDA's allulose enforcement-discretion policy, which previously allowed allulose to be excluded from 'total sugars' on nutrition labels. This situation highlights a critical disconnect between regulatory guidance and consumer perception, emphasizing the need for clearer labeling standards to prevent consumer deception and ensure transparency in product claims.
What's Next?
As these cases continue to move through the court system, companies marketing allulose-containing products may want to act now to evaluate and mitigate potential litigation exposure. This involves identifying all allulose-containing products with sugar-related claims and assessing them against FDA standards, particularly whether allulose content exceeds the 0.5-gram threshold for 'sugar-free' claims. Companies are also cautioned not to rely solely on FDA enforcement discretion as a safe harbor from consumer class action lawsuits, as such discretion does not alter governing regulations or prevent challenges under state consumer protection laws. The outcome of these lawsuits, especially the ongoing case against Chobani, will likely set precedents for how 'zero sugar' claims are interpreted and enforced for products containing allulose, potentially leading to widespread changes in product labeling and marketing strategies across the food and beverage industry.
Beyond the Headlines
The legal challenges surrounding allulose and 'zero sugar' claims underscore a broader ethical and regulatory debate about how food products are marketed to health-conscious consumers. The increasing demand for low-sugar options has led to the widespread adoption of alternative sweeteners, but the nuances of their classification and consumer understanding remain complex. This situation highlights the importance of clear, unambiguous labeling that accurately reflects a product's nutritional content and avoids misleading consumers. It also brings to light the power of consumer advocacy and class action lawsuits in holding companies accountable for their marketing claims, even when regulatory bodies might offer some flexibility. Ultimately, this could lead to a more stringent environment for food labeling, pushing companies to be more precise and transparent about ingredients and their health implications.
